Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

LogicBio Therapeutics (LOGC) Short Interest Ratio & Short Volume

LogicBio Therapeutics logo
$8.56 -0.21 (-2.37%)
As of 03:55 PM Eastern
Compare

LogicBio Therapeutics Short Interest Overview

As of April 30, 2026, LogicBio Therapeutics (LOGC) had a short interest of 557,865 shares sold short, representing 2.12% of the public float. This marks a -0.31% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.6, meaning it would take 3.6 days of the average trading volume of 146,090 shares to cover all short positions.

Current Short Interest
557,865 shares
Previous Short Interest
559,586 shares
Change Vs. Previous Month
-0.31%
Dollar Volume Sold Short
$4.75 million
Short Interest Ratio
3.6 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
45,670,000 shares
Short Percent of Float
2.12%
Today's Trading Volume
149,469 shares
Average Trading Volume
146,090 shares
Today's Volume Vs. Average
102%
Short Selling LogicBio Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for LogicBio Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LOGC Short Interest Over Time

LOGC Days to Cover Over Time

LOGC Percentage of Float Shorted Over Time

LogicBio Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026557,865 shares $4.75 million -0.3%2.1%3.63 $8.52
10/15/2025610,000 shares $4.73 million -9.9%2.5%4.4 $7.75
9/30/2025677,100 shares $5.41 million -15.2%N/A2.4 $7.99
9/15/2025798,100 shares $6.25 million -8.1%N/A5 $7.83
8/31/2025868,100 shares $6.44 million -7.1%3.6%11.9 $7.42
8/15/2025934,400 shares $6.89 million -10.5%N/A7.2 $7.37
7/31/20251,044,400 shares $7.96 million -6.0%4.3%5.6 $7.62
7/15/20251,110,600 shares $7.94 million -6.0%N/A4.7 $7.15
6/30/20251,181,400 shares $7.86 million -24.0%4.9%1.6 $6.65
6/15/20251,555,300 shares $12.71 million -31.0%6.4%0.6 $8.17
5/31/20252,250,000 shares $18.45 million -2.2%9.5%4.4 $8.20
5/15/20252,300,000 shares $16.95 million -9.8%9.7%6.4 $7.37
4/30/20252,550,000 shares $18.21 million -2.3%10.9%7.5 $7.14
4/15/20252,610,000 shares $17.12 million No Change11.1%7.9 $6.56
3/31/20252,610,000 shares $18.14 million +2.0%11.1%8.7 $6.95
3/15/20252,560,000 shares $19.32 million +1.6%10.9%9 $7.55
2/28/20252,520,000 shares $21.70 million +1.6%10.7%9.1 $8.61
2/15/20252,480,000 shares $19.69 million -2.4%10.6%10 $7.94
1/31/20252,540,000 shares $18.85 million -6.3%10.8%10.9 $7.42
1/15/20252,710,000 shares $17.51 million -0.4%11.5%10.9 $6.46
12/31/20242,720,000 shares $19.26 million -3.2%11.6%10.3 $7.08
12/15/20242,810,000 shares $21.05 million -5.1%12.0%10.1 $7.49
11/30/20242,960,000 shares $21.16 million -7.2%13.2%10.6 $7.15
11/15/20243,190,000 shares $20.37 million -2.5%14.2%11.9 $6.39
10/31/20243,270,000 shares $21.22 million -0.9%14.2%12.5 $6.49
10/15/20243,300,000 shares $19.44 million +25.0%14.9%11.8 $5.89
9/30/20242,640,000 shares $14.39 million -15.7%12.0%9.5 $5.45
9/15/20243,130,000 shares $16.68 million +20.4%14.2%9.5 $5.33
8/31/20242,600,000 shares $14.04 million -6.1%11.9%7.5 $5.40
8/15/20242,770,000 shares $15.15 million +14.0%12.7%7.3 $5.47
7/31/20242,430,000 shares $13.12 million -33.8%12.0%5.8 $5.40
7/15/20243,670,000 shares $22.39 million No Change18.1%6.9 $6.10
10/31/2022274,400 shares $562.52 thousand +104.9%1.3%0.5 $2.05
10/15/2022133,900 shares $274.50 thousand +159.5%0.7%0.3 $2.05
9/30/202251,600 shares $14.06 thousand +77.3%0.3%0.1 $0.27
9/15/202229,100 shares $10.91 thousand -61.1%0.2%0.2 $0.38
8/31/202274,800 shares $26.81 thousand -2.7%0.4%0.4 $0.36
8/15/202276,900 shares $39.60 thousand +18.7%0.4%0.3 $0.52
7/31/202264,800 shares $25.43 thousand -8.7%0.4%0.1 $0.39
7/15/202271,000 shares $27.69 thousand +110.7%0.4%0.1 $0.39
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.tc pixel

Watch the free video to get the ticker today.
6/30/202233,700 shares $11.80 thousand -75.8%0.2%0 $0.35
6/15/2022139,100 shares $60.51 thousand -37.6%0.8%0.1 $0.44
5/31/2022222,800 shares $111.40 thousand -57.6%1.2%0.2 $0.50
5/15/2022526,000 shares $226.18 thousand +952.0%2.9%0.4 $0.43
4/30/202250,000 shares $22 thousand -60.9%0.3%0 $0.44
4/15/2022127,800 shares $86.14 thousand -0.1%0.7%0.4 $0.67
3/31/2022127,900 shares $86.98 thousand -10.0%0.7%0.4 $0.68
3/15/2022142,100 shares $99.19 thousand -11.9%0.8%0.4 $0.70
2/28/2022161,200 shares $106.39 thousand -39.3%0.9%0.5 $0.66
2/15/2022265,500 shares $196.47 thousand +60.0%1.5%0.9 $0.74
1/31/2022165,900 shares $248.85 thousand -5.8%0.9%0.6 $1.50
1/15/2022176,100 shares $343.40 thousand -4.3%1.4%1.9 $1.95
12/31/2021184,000 shares $425.04 thousand -31.6%1.4%1.9 $2.31
12/15/2021268,800 shares $658.56 thousand -55.0%2.1%2.8 $2.45
11/30/2021597,600 shares $1.79 million -0.5%4.8%7.5 $3.00
11/15/2021600,300 shares $2.11 million -0.7%4.8%7.4 $3.52
10/29/2021604,200 shares $2.21 million +0.8%4.9%7.6 $3.65
10/15/2021599,700 shares $2.40 million +1.9%4.9%7.1 $4.00
9/30/2021588,400 shares $2.69 million +1.9%4.8%6.7 $4.58
9/15/2021577,200 shares $2.61 million +2.2%4.7%4.3 $4.53
8/31/2021564,900 shares $2.68 million -17.3%4.6%3.5 $4.74
8/13/2021682,800 shares $3.08 million -1.9%5.6%3.9 $4.51
7/30/2021696,300 shares $2.90 million -4.0%5.7%3.8 $4.17
7/15/2021724,900 shares $2.79 million -1.2%4.0%3.6 $3.85
6/30/2021733,500 shares $3.26 million -31.5%4.1%3.7 $4.44
6/15/20211,070,000 shares $4.74 million +5.9%6.0%6.5 $4.43
5/28/20211,010,000 shares $4.41 million -2.9%5.6%7.1 $4.37

LOGC Short Interest - Frequently Asked Questions

Short interest is the volume of LogicBio Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 557,865 shares of LOGC short. 2.12% of LogicBio Therapeutics' shares are currently sold short. Learn More on LogicBio Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LOGC shares currently have a short interest ratio of 3.6. Learn More on LogicBio Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.12% of LogicBio Therapeutics' floating shares are currently sold short.

LogicBio Therapeutics saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 557,865 shares, a decrease of 0.3% from the previous total of 559,586 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.12% of LogicBio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "retail/wholesale" compare to LogicBio Therapeutics: Yesway, Inc. (0.63%), Bob's Discount Furniture, Inc. (5.72%), The Wendy's Company (29.32%), Travis Perkins PLC (0.03%), Hotel101 Global Holdings Corp. (0.00%), Ryerson Holding (3.22%), Herbalife Ltd (8.48%), Kohl's Corporation (23.63%), Winmark Corporation (10.01%), 361 Degrees International Limited (0.26%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling LOGC is an investing strategy that aims to generate trading profit from LogicBio Therapeutics as its price is falling. LOGC shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for LogicBio Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LOGC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LOGC, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LOGC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (OTCMKTS:LOGC) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel